Current Edition

Volume 14 Issue 4

EU CTR: Final Countdown, What You Need to Know

The end of the transition period is imminent. How can clinical trial sponsors and CROs ease the transition to CTIS? Soon, the one-year transition period of the EU...
Continue Reading →
News

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive...
Continue Reading →
News

Brussels Airport launches blockchain application on their winning BRUcloud data sharing platform

Last month, during the Air China Cargo exhibition in Shanghai, Brussels Airport and their cargo community won the award for “IT solution of the year” with BRUclo...
Continue Reading →
News

Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations

Invivoscribe Technologies, Inc. announced today that they have submitted to Japan's Pharmaceutical and Medical Devices Agency (PMDA) and the US Food and Drug Adminis...
Continue Reading →
News

Starpharma completes US New Drug Application for VivaGel BV

VivaGel BV stands to be the first and only product approved for the prevention of recurrent BV Australian pharma giant Starpharma today announced that its rollin...
Continue Reading →
News

Wickham Laboratories Holdings Announces Planning Application Approval

Outline planning permission application for expansion of the Hoeford Point site now approved. Wickham Laboratories Holdings, owner of Wickham Laboratories Ltd...
Continue Reading →
News

Elpis BioMed closes funding round to commercialise novel technology platform for generating human cell types

Elpis BioMed Ltd (Elpis), a University of Cambridge spin-out, applying its disruptive and proprietary “direct cell reprogramming” platform to produce pure, mature an...
Continue Reading →
Extending Your Patent on a New Application for an Old Drug
Regulatory & Marketplace v4i3

Extending Your Patent on a New Application for an Old Drug

Extending Your Patent on a New Application for an Old Drug     The period that is necessary to obtain a marketing authorisation to bring a n...
Continue Reading →